Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

This growth was primarily driven by the performance of key products such as Mounjaro, Zepbound, and Verzenio, offset partially by Trulicity. Eli Lilly's clinical development pipeline remains robust, ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli ...

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...

We recently published a list of Top 10 Stocks to Buy According to Sustainable Insight Capital Management. In this article, we ...

Sustainable Insight Capital Management (SICM) focuses on institutional investments, offering both long-only and long-short ...

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are presently covering the stock, ...